Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
BlackRock, Inc.'s stake in Apellis Pharmaceuticals, Inc. fell to 4.50% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 25, 2025
BlackRock, Inc.'s stake in Apellis Pharmaceuticals, Inc. fell to 4.50%, 5,598,572 shares, as a passive investor on Mar 31, 2025. Filed Apr 25, 2025 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 5,598,572
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.50% | 5,598,572 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- BlackRock, Inc.
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Feb 6, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026